The Pharmacogenomic Era: Promise for Personalizing Attention Deficit Hyperactivity Disorder Therapy

This publication has 57 references indexed in Scilit:

• Influence of Ethanol and Gender on Methylphenidate Pharmacokinetics and Pharmacodynamics
  Clinical Pharmacology & Therapeutics, 2007
• No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention‐deficit/hyperactivity disorder
  American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2006
• Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD
  American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2006
• Association of 4-Repeat Allele of the Dopamine D4 Receptor Gene Exon III Polymorphism and Response to Methylphenidate Treatment in Korean ADHD Children
  Neuropsychopharmacology, 2006
• Dopamine Transporter Genotype and Methylphenidate Dose Response in Children with ADHD
  Neuropsychopharmacology, 2005
• The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate
  European Neuropsychopharmacology, 2005
• Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study
  Pediatrics, 2001
• Initial sequencing and analysis of the human genome
  Nature, 2001
• Pharmacokinetic and Pharmacodynamic Drug Interactions in the Treatment of Attention-Deficit Hyperactivity Disorder
  Clinical Pharmacokinetics, 2001
• MOLECULAR MECHANISMS OF GENETIC POLYMORPHISMS OF DRUG METABOLISM
  Annual Review of Pharmacology and Toxicology, 1997